1 / 3

Leukapheresis Market Dynamics, Share, Size, and Outlook By 2023

Leukapheresis Market Dynamics, Share, Size, and Outlook By 2023

sandipkumar38491
Télécharger la présentation

Leukapheresis Market Dynamics, Share, Size, and Outlook By 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Leukapheresis Market Dynamics, Share, Size, and Outlook By 2023 Leukapheresis Market Size and Trends Analysis By Type (Leukapheresis Devices, Leukapheresis Disposables), by Application (Research Applications, Therapeutic Applications), By End User (Blood Component Provider and Blood Center, Other) - Forecast Till 2023 Regional Analysis: Geographically, the Americas is anticipated to dominate the global leukapheresis products market owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region. Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East & Africa has the least share of the global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region. Key Players: Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress Segmentation: The global leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters. The market, by application, has been segmented into research applications and therapeutic applications. On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.

  2. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6767 Market Highlights: Leukapheresis is a laboratory procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is anticipated that the leukapheresis market held a value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period. Currently, many companies are operating in the global leukapheresis products market. The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations. The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical research are anticipated to propel the growth of the market over the forecast period. According to the National Institutes of Health (NIH) estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the period from 2006-2015. It also stated that the number of new cases may reach 60,300 in the year 2018. Despite the drivers, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hamper the market growth over the assessment period. Brows More Healthcare Related Research Reports at: Global Suture wire Market Research Report - Forecast to 2023 | MRFR Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023 Nanobots Market Size, Trends | Insights and Share Analysis, 2023 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details. Contact: Market Research Future

  3. Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India +1 646 845 9312 Email: sales@marketresearchfuture.com .

More Related